Having trouble accessing articles? Reset your cache.

NICE issues Xeloda, MabThera, Iressa guidance

The U.K.'s NICE issued guidance for three cancer drugs on Wednesday, including two from Roche (SIX:ROG; OTCQX:RHHBY)

Read the full 176 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE